{"version":"1.0","type":"rich","provider_name":"Acast","provider_url":"https://acast.com","height":250,"width":700,"html":"<iframe src=\"https://embed.acast.com/$/65736d39d32e730012c98919/694443fff13209aaa3e2a7cc?\" frameBorder=\"0\" width=\"700\" height=\"250\"></iframe>","title":"Editors’ Choice: Top Stories of 2025","description":"<p>In the final episode of 2025, the <em>GEN</em> team came together to reflect on some of the stories over the last year that they each found impactful. Some of the stories were covered in <em>GEN</em>’s December issue, but our editors took the time to discuss some topics in a bit more depth during the podcast. The discussion began with an update on the progress of AI use in drug discovery. Cell and gene therapy was a big topic with the positive outcome for Baby KJ, while Sarepta dealt with a rollercoaster of a year with their DMD treatment, Elevidys. Research and biotech in Africa are growing and the discussion ranged from challenges to promise in research and development on the continent. This year’s NIH budget cuts and impacted institutions rounded out the conversation.</p><p><br></p><p>Join <em>GEN</em> editors Corinna Singleman, PhD, Alex Philippidis, Fay Lin, Phd, Kevin Davies, Phd, John Sterling, and Uduak Thomas for a discussion of the latest biotech and biopharma news.&nbsp;</p><p>Listed below are links to the <em>GEN</em> stories referenced in this episode of <em>Touching Base</em>:&nbsp;</p><p>&nbsp;</p><p><a href=\"https://www.genengnews.com/industry-news/gen-editors-reflect-on-six-of-the-biggest-stories-of-the-year/\" rel=\"noopener noreferrer\" target=\"_blank\"><em>GEN</em> Editors Reflect on Six of the Biggest Stories of the Year</a></p><p>By Alex Philippidis, Savannah Wiegel, Fay Lin, PhD, Kevin Davies, PhD, Uduak Thomas, and Julianna LeMieux, PhD, <em>GEN</em>, December 4, 2025</p><p><br></p><p><a href=\"https://www.genengnews.com/topics/genome-editing/stockwatch-sarepta-says-deaths-of-two-elevidys-patients-posted-on-fda-database-unrelated-to-treatment/\" rel=\"noopener noreferrer\" target=\"_blank\">StockWatch: Sarepta Says Deaths of Two Elevidys Patients Posted on FDA Database Unrelated to Treatment</a> </p><p>By Alex Philippidis, <em>GEN Edge</em>, August 10</p><p><br></p><p> <a href=\"https://www.genengnews.com/topics/genome-editing/stockwatch-as-prasad-exits-fda-analysts-see-benefit-for-sarepta-cgt-stocks/\" rel=\"noopener noreferrer\" target=\"_blank\">StockWatch: As Prasad Exits FDA, Analysts See Benefit for Sarepta, CGT Stocks</a> </p><p>By Alex Philippidis, <em>GEN Edge</em>, August 3</p><p><br></p><p> <a href=\"https://www.genengnews.com/topics/genome-editing/fda-probes-death-of-brazilian-boy-linked-to-sareptas-elevidys/\" rel=\"noopener noreferrer\" target=\"_blank\">FDA Probes Death of Brazilian Boy Linked to Sarepta’s Elevidys</a> </p><p><em>GEN Edge</em>, July 27</p><p><br></p><p> <a href=\"https://www.genengnews.com/topics/genome-editing/second-dmd-patient-dies-after-treatment-with-sarepta-gene-therapy/\" rel=\"noopener noreferrer\" target=\"_blank\">Second DMD Patient Dies After Treatment with Sarepta Gene Therapy</a> </p><p>By Alex Philippidis, <em>GEN Edge</em>, June 15 </p><p><br></p><p> <a href=\"https://www.genengnews.com/topics/genome-editing/dmd-patient-dies-after-treatment-with-sarepta-gene-therapy/\" rel=\"noopener noreferrer\" target=\"_blank\">DMD Patient Dies After Treatment with Sarepta Gene Therapy</a> </p><p>By Alex Philippidis, <em>GEN Edge</em>, March 18</p><p><br></p><p><a href=\"https://www.genengnews.com/magazine/volume-45/issue-no-12-december-2025/\" rel=\"noopener noreferrer\" target=\"_blank\">From The Editor in Chief</a></p><p>John Sterling, December Issue of <em>GEN</em></p><p><em>&nbsp;</em></p><p><a href=\"https://www.genengnews.com/topics/genome-editing/gene-therapy-in-africa/\" rel=\"noopener noreferrer\" target=\"_blank\">Gene Therapy in Africa</a></p><p>The State of CRISPR &amp; Genome Editing Summit, June 11, 2025</p><p><br></p><p><a href=\"https://www.genengnews.com/industry-news/top-50-nih-funded-institutions-of-fy-2025/\" rel=\"noopener noreferrer\" target=\"_blank\">TOP 50 NIH</a> </p><p>By Alex Philippidis, <em>GEN</em>, December 4, 2025</p><p><br></p><p> <a href=\"https://www.genengnews.com/gen-edge/cell-and-gene-therapy-leaders-tell-fda-believe-in-american-solutions/\" rel=\"noopener noreferrer\" target=\"_blank\"><em>FDA Cell &amp; Gene Therapy roundtable</em>: Cell and Gene Therapy Leaders Tell FDA: “Believe in American Solutions”</a> </p><p>By Alex Philippidis, and Kevin Davies, PhD, <em>GEN Edge</em>, June 5, 2025</p><p><br></p><p><a href=\"https://www.genengnews.com/topics/translational-medicine/scientists-in-nyc-rally-to-defend-and-stand-up-for-science/\" rel=\"noopener noreferrer\" target=\"_blank\">Scientists in NYC Rally to Defend and Stand Up for Science</a></p><p>By Corinna Singleman, <em>GEN</em>, March 10, 2025</p><p><br></p><p><a href=\"https://www.genengnews.com/category/multimedia/podcasts/touching-base/\" rel=\"noopener noreferrer\" target=\"_blank\"><em>Touching Base</em> Podcast</a>&nbsp;</p><p>Hosted by Corinna Singleman, PhD&nbsp;</p><p>&nbsp;</p><p><a href=\"https://www.insideprecisionmedicine.com/category/multimedia/podcasts/\" rel=\"noopener noreferrer\" target=\"_blank\"><em>Behind the Breakthroughs</em></a><em>&nbsp;</em></p><p>Hosted by Jonathan D. Grinstein, PhD&nbsp;</p>","author_name":"Genetic Engineering & Biotechnology News (GEN)"}